J. Rojouan

Relationship of histological subtypes to prognosis in early stage Hodgkin's disease: a review of 312 cases in a controlled clinical trial. The Groupe Pierre et Marie Curie.

J. Diebold, S. Culine, M. Henry-Amar, 1989, European journal of cancer & clinical oncology.

Early phase of vincristine neuropathy in man Electrophysiological evidence for a dying-back phenomenon, with transitory enhancement of spinal transmission of the monosynaptic reflex

P. Guiheneuc, J. Rojouan, J. Ginet, 1980, Journal of the Neurological Sciences.

Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease

J. Rojouan, R. Zittoun, H. Eghbali, 1991, Journal of Cancer Research and Clinical Oncology.

[Epidemiologic approach to Horton's disease in the department of Loire-Atlantique. 110 cases in 10 years (1970-1979)].

R. Massari, J. Rojouan, P. Peltier, 1982, La Revue de medecine interne.

Combination of ABVD and radiotherapy in early stages of Hodgkin's disease: analysis of a series of 94 patients. Pierre and Marie Curie Group (GPMC).

A. Audebert, B. Hoerni, J. Rojouan, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.

J. Diebold, H. Merle-Beral, A. Audebert, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Outcome, treatment and prognosis of Horton's disease].

J. Rojouan, G. Potel, J. Grolleau, 1983, Annales de medecine interne.

[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].

A. Audebert, B. Hoerni, J. Rojouan, 1987, Bulletin du cancer.